Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
Not yet recruiting · NCT05106127 · Registry updated 2025-12-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem | Advanced Endometrial Cancer | Not yet recruiting | Phase 2 | 2025-12-08 | NCT05106127 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Evergreen Therapeutics, Inc. | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||